Comparing two methods for pain control after hip fracture surgery
Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture
This study is testing whether a new pain control method using cryoablation works better than a standard method for people aged 18 to 85 after hip fracture surgery.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | University of Minnesota Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Trial ID | NCT06278987 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the effectiveness of cryoablation of the pericapsular nerve group (PENG) versus a fascia iliaca catheter for pain management in patients undergoing hip fracture repair. It will assess pain control outcomes 30 days post-surgery in participants aged 18 to 85. The study will involve administering either the PENG block with cryoablation or the fascia iliaca compartment block to evaluate which method provides better pain relief. The findings could help refine pain management strategies for hip fracture patients.
Who should consider this trial
Good fit: Ideal candidates are patients aged 18-85 who are undergoing surgical repair for a hip fracture.
Not a fit: Patients who have contraindications to regional anesthesia or who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management techniques for patients recovering from hip fractures.
How similar studies have performed: Other studies have explored nerve blocks for pain management, but this specific comparison of cryoablation and fascia iliaca catheter is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing hip fracture repair aged 18-85. Exclusion Criteria: * Patients who have an exclusion to regional anesthesia. * Patients who are pregnant assessed via self-report or pregnancy test if they have taken one. * Non-English speakers * Patients who already had their fracture repaired"
Where this trial is running
Minneapolis, Minnesota
- University of Minnesota — Minneapolis, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Jason Habeck — University of Minnesota
- Study coordinator: Candace Nelson
- Email: nelso377@umn.edu
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.